819results about How to "Low water solubility" patented technology

A dermatological composition comprising a salt of a cation and an anion. The cation is derived from a monomeric or polymeric molecule that will generate an amidine moieity, a guanidine moieity or a biguanide moieity. The anion is derived from a monomeric or polymeric molecule that will generate a carboxylic acid moieity. The composition may be prepared by a metathesis or acid-base reaction.

Disclosed is a method for delivery of at least one therapeutic agent from an angioplasty balloon for treating vascular disease at a bifurcated vessel. The invention also relates to the method of loading the beneficial agents onto the balloon and the device, as well as the method of delivery of the agents from separate surfaces. The invention also relates to a method of loading multiple beneficial agents onto the balloon surfaces

Drugs, especially low aqueous solubility drugs, are provided in a porous matrix form, preferably microparticles, which enhances dissolution of the drug in aqueous media. The drug matrices preferably are made using a process that includes (i) dissolving a drug, preferably a drug having low aqueous solubility, in a volatile solvent to form a drug solution, (ii) combining at least one pore forming agent with the drug solution to form an emulsion, suspension, or second solution and hydrophilic or hydrophobic excipients that stabilize the drug and inhibit crystallization, and (iii) removing the volatile solvent and pore forming agent from the emulsion, suspension, or second solution to yield the porous matrix of drug. Hydrophobic or hydrophilic excipients may be selected to stabilize the drug in crystalline form by inhibiting crystal growth or to stabilize the drug in amorphous form by preventing crystallization. The pore forming agent can be either a volatile liquid that is immiscible with the drug solvent or a volatile solid-compound, preferably a volatile salt. In a preferred embodiment, spray drying is used to remove the solvents and the pore forming agent. The resulting porous matrix has a faster rate of dissolution following administration to a patient, as compared to non-porous matrix forms of the drug. In a preferred embodiment, microparticles of the porous drug matrix are reconstituted with an aqueous medium and administered parenterally, or processed using standard techniques into tablets or capsules for oral administration.

The invention relates to pharmaceutical compositions comprising propylene glycol solvates of APIs.

A herbicidal composition comprises in aqueous solution a mixture of salts of glyphosate at a total glyphosate a.e. concentration not less than about 360 g/l, wherein (a) said glyphosate is in anionic form accompanied by low molecular weight non-amphiphilic cations in a total molar amount of about 100% to about 120% of the molar amount of said glyphosate; (b) said cations comprise potassium and propylammonium (e.g., isopropylammonium) cations in a mole ratio of about 70:30 to about 90:10; and (c) said potassium and propylammonium cations together constitute about 90 to 100 molar percent of all of said low molecular weight non-amphiphilic cations in the composition.

A microsoftgel coated ammonium polyphosphate is prepared through suspending the ammonium polyphosphate particles in disperser, adding melamine, formaldehyde and hardening agent at 60-150 deg.C, stirring while reaction, adding formaldehyde capture, stirring while reacting at 30-60 deg.C for 10-30 min, filtering and drying. It can be used as flame-retarding agent.

Chewing gums and methods of making same that have prolonged and enhanced sensory benefits are provided. The chewing gums of the present invention include a hydrophobic sweetener, a sensorally active component or trigeminal stimulant, such as a flavor, in addition to other typical chewing gum ingredients. The hydrophobic sweeteners are composed of sweet organic compounds that have a low water solubility.

A cleaning solution for cleaning a substrate for semiconductor devices and a cleaning method using the said cleaning solution, which comprises at least the following components (A), (B) and (C): (A) an ethyleneoxide-type surfactant containing a hydrocarbon group which may have a substituent group except for phenyl, and a polyoxyethylene group in which a ratio (m/n) of a number (m) of carbon atoms contained in the hydrocarbon group to a number (n) of oxyethylene groups contained in the polyoxyethylene group is in the range of 1 to 1.5, the number (m) of carbon atoms is not less than 9, and the number (n) of oxyethylene groups is not less than 7; (B) water; and (C) alkali or an organic acid. The cleaning solution highly clean the surface of the substrate without occurrence of corrosion by removing fine particles and organic contaminants which are adhered onto the surface of the substrate.

Uncoated particles of reversed cubic phase or reversed hexagonal phase material containing an active disposed within are provided. The uncoated particles have an ionic charge that is sufficient to stabilize them in dispersion in a liquid, e.g. a polar solvent. The active that is disposed within the particles may be, for example, a pharmaceutical or nutriceutical compound.

The invention relates to a method for efficiently extracting lithium from salt lake brine. The method comprises the following steps: (1) forming an extraction organic phase by an extraction agent, a co-extraction agent and a diluent, and then mixing the extraction organic phase with salt lake brine according to the volume ratio of (3-4):2 for three-stage extraction with single extraction time being 2-10 minutes to obtain an organic phase; and (2) mixing the organic phase obtained in step (1) with a reverse extraction acid solution (0-1 mol/L) for three-stage reverse extraction with single reverse extraction time being 2-10 minutes, and collecting an aqueous phase which is an aqueous solution containing lithium ions. The co-extraction agent of an extraction system of the method is hydrophobic ionic liquid, compared with conventional synergist ferric trichloride, the interference caused by iron ions is avoided, the reverse extraction acidity is greatly reduced, more importantly the lithium-magnesium separation factor is significantly improved, and the elution step of magnesium ions is reduced; in addition, the method provided by the invention is easy in process, easy to control, high in operation reliability, and good in recyclability of the organic phase, and greatly reduces the production cost for extracting the lithium from the salt lake brine.

The invention relates to an ammonium polyphosphate and montmorillonite nano compound and a preparation method thereof, which belong to the phosphorous compound preparation, composition, modification and crystalline control field. The method for preparing the nano compound comprises the following steps: montmorillonite is added during the preliminary stage of the process of general preparation of ammonium polyphosphate; ammonia is passed through when the temperature is raised to between 150 and 300 DEG C; heat preservation is performed when the temperature is raised to between 300 and 350 DEG C; and then the ammonium polyphosphate and montmorillonite nano compound are obtained after continuous ammoniation for 30 to 200 minutes. The preparation method controls the purity of an I-type polyphosphoric acid in the product through addition of a specific amount of the montmorillonite; the ammonium polyphosphate completely off a silicate slice of the montmorillonite; and nano-dispersion is formed in the ammonium polyphosphate, and then the ammonium polyphosphate and montmorillonite nano compound is obtained. The nano compound reduces the water solubility of the ammonium polyphosphate, has the function of improving the flame-retardant effect in inflaming retarding of polymer materials, and has the advantages of simple preparation technology and raw materials and low cost.

The present invention relates to novel amino acid salts of fumaric acid monoalkylesters. The salts are suitable for use as active substances in the treatment of e.g. psoriasis or other hyperproliferative, inflammatory or autoimmune disorders.

The present invention relates to compositions and methods for enhancing the bioavailability of beneficial agents with low water solubility.

N-[1S,2S]-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-{[5-trifluoromethyl]pyridine-2-yl}oxy}propanamide (Compound I) has surprisingly improved solubility and bioavailability in a lipophilic vehicle comprising a pharmaceutically acceptable digestible oil, a surfactant, or a cosolvent, or a mixture of any two or more thereof. In one embodiment of the present invention are self-emulsifying or self-microemulsifying composition comprising 1) Compound I; 2) a surfactant having an HLB of 1 to 8; and 3) a surfactant having an HLB of over 8 to 20; and optionally, 4) a digestible oil and/or cosolvent and/or antioxidant or preservative.

A process for the preparation of a particulate material by a controlled agglomeration method, i.e. a method that enables a controlled growth in particle size. The method is especially suitable for use in the preparation of pharmaceutical compositions containing a therapeutically and/or prophylactically active substance which has a relatively low aqueous solubility and/or which is subject to chemical decomposition. The process comprising i) spraying a first composition comprising a carrier, which has a melting point of about 5° C. or more which is present in the first composition in liquid form, on a second composition comprising a material in solid form, the second composition having a temperature of at the most a temperature corresponding to the melting point of the carrier and/or the carrier composition and ii) mixing or others means of mechanical working the second composition onto which the first composition is sprayed to obtain the particulate material.

The invention discloses a carboxylic acid compound as well as a preparation method and application thereof. When the carboxylic acid compound is applied to extraction separation of metal ions, the separation coefficient is high, the reverse extraction acidity is low, the load rate is high, and the reverse extraction rate is high. The carboxylic acid compound serving as an extraction agent is highin stability and low in water solubility, so that the extraction process is stable, the environmental pollution can be reduced, and the cost is reduced. The carboxylic acid compound disclosed by the invention is low in cost, has a great application prospect and can be used for various systems such as ternary battery recovery and battery-grade nickel sulfate preparation.

The disclosed preparation method for chitose/chitosan oligosaccharide with low molecular weight as 0.18-15mega and well water-solubility comprises: preparing water-soluble chitosan by acetylization; degrading the product with non-specific hydrolase while controlling the enzyme dosage and reaction time; adjusting the degraded product pH value to 8-9 with KOH or NaOH solution; depositing with ethanol, cleaning, and vacuum drying the final product with free amidogen that can promote wound healing, restrains tumor cell growth and improves human immunity. Compared with prior art, this invention is convenient to control for wide application.